The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal Drug Compounding-Global Market Insights and Sales Trends 2024
Synopsis
Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
The global Animal Drug Compounding market size is expected to reach US$ 1286.2 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Drug Compounding in various end use industries. The expanding demands from the Veterinary Hospitals, Veterinary Clinics and Veterinary Diagnostic Centers,, are propelling Animal Drug Compounding market. Anti-Infective Agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormones and Substitutes segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Drug Compounding, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Drug Compounding market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Drug Compounding market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Drug Compounding sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Drug Compounding covered in this report include Triangle Compounding Pharmacy, Lorraine's Pharmacy, Medisca, Diamondback Drugs and ESSENTIAL PHARMACY COMPOUNDING VET, etc.
The global Animal Drug Compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
Global Animal Drug Compounding market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Drug Compounding market, Segment by Type:
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
Global Animal Drug Compounding market, by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal Drug Compounding manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal Drug Compounding in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
The global Animal Drug Compounding market size is expected to reach US$ 1286.2 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Drug Compounding in various end use industries. The expanding demands from the Veterinary Hospitals, Veterinary Clinics and Veterinary Diagnostic Centers,, are propelling Animal Drug Compounding market. Anti-Infective Agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormones and Substitutes segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Drug Compounding, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Drug Compounding market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Drug Compounding market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Drug Compounding sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Drug Compounding covered in this report include Triangle Compounding Pharmacy, Lorraine's Pharmacy, Medisca, Diamondback Drugs and ESSENTIAL PHARMACY COMPOUNDING VET, etc.
The global Animal Drug Compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
Global Animal Drug Compounding market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Drug Compounding market, Segment by Type:
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
Global Animal Drug Compounding market, by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal Drug Compounding manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal Drug Compounding in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Animal Drug Compounding Market Overview
1.1 Animal Drug Compounding Product Overview
1.2 Animal Drug Compounding Market Segment by Type
1.2.1 Anti-Infective Agents
1.2.2 Hormones and Substitutes
1.2.3 Anti-Inflammatory Agents
1.2.4 Others
1.3 Global Animal Drug Compounding Market Size by Type
1.3.1 Global Animal Drug Compounding Market Size Overview by Type (2018-2029)
1.3.2 Global Animal Drug Compounding Historic Market Size Review by Type (2018-2023)
1.3.3 Global Animal Drug Compounding Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Animal Drug Compounding Sales Breakdown by Type (2018-2023)
1.4.2 Europe Animal Drug Compounding Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Animal Drug Compounding Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Animal Drug Compounding Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Animal Drug Compounding Sales Breakdown by Type (2018-2023)
2 Global Animal Drug Compounding Market Competition by Company
2.1 Global Top Players by Animal Drug Compounding Sales (2018-2023)
2.2 Global Top Players by Animal Drug Compounding Revenue (2018-2023)
2.3 Global Top Players by Animal Drug Compounding Price (2018-2023)
2.4 Global Top Manufacturers Animal Drug Compounding Manufacturing Base Distribution, Sales Area, Product Type
2.5 Animal Drug Compounding Market Competitive Situation and Trends
2.5.1 Animal Drug Compounding Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Animal Drug Compounding Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Drug Compounding as of 2022)
2.7 Date of Key Manufacturers Enter into Animal Drug Compounding Market
2.8 Key Manufacturers Animal Drug Compounding Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Animal Drug Compounding Status and Outlook by Region
3.1 Global Animal Drug Compounding Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Animal Drug Compounding Historic Market Size by Region
3.2.1 Global Animal Drug Compounding Sales in Volume by Region (2018-2023)
3.2.2 Global Animal Drug Compounding Sales in Value by Region (2018-2023)
3.2.3 Global Animal Drug Compounding Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Animal Drug Compounding Forecasted Market Size by Region
3.3.1 Global Animal Drug Compounding Sales in Volume by Region (2024-2029)
3.3.2 Global Animal Drug Compounding Sales in Value by Region (2024-2029)
3.3.3 Global Animal Drug Compounding Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Animal Drug Compounding by Application
4.1 Animal Drug Compounding Market Segment by Application
4.1.1 Veterinary Hospitals
4.1.2 Veterinary Clinics
4.1.3 Veterinary Diagnostic Centers
4.2 Global Animal Drug Compounding Market Size by Application
4.2.1 Global Animal Drug Compounding Market Size Overview by Application (2018-2029)
4.2.2 Global Animal Drug Compounding Historic Market Size Review by Application (2018-2023)
4.2.3 Global Animal Drug Compounding Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Animal Drug Compounding Sales Breakdown by Application (2018-2023)
4.3.2 Europe Animal Drug Compounding Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Animal Drug Compounding Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Animal Drug Compounding Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Animal Drug Compounding Sales Breakdown by Application (2018-2023)
5 North America Animal Drug Compounding by Country
5.1 North America Animal Drug Compounding Historic Market Size by Country
5.1.1 North America Animal Drug Compounding Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Animal Drug Compounding Sales in Volume by Country (2018-2023)
5.1.3 North America Animal Drug Compounding Sales in Value by Country (2018-2023)
5.2 North America Animal Drug Compounding Forecasted Market Size by Country
5.2.1 North America Animal Drug Compounding Sales in Volume by Country (2024-2029)
5.2.2 North America Animal Drug Compounding Sales in Value by Country (2024-2029)
6 Europe Animal Drug Compounding by Country
6.1 Europe Animal Drug Compounding Historic Market Size by Country
6.1.1 Europe Animal Drug Compounding Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Animal Drug Compounding Sales in Volume by Country (2018-2023)
6.1.3 Europe Animal Drug Compounding Sales in Value by Country (2018-2023)
6.2 Europe Animal Drug Compounding Forecasted Market Size by Country
6.2.1 Europe Animal Drug Compounding Sales in Volume by Country (2024-2029)
6.2.2 Europe Animal Drug Compounding Sales in Value by Country (2024-2029)
7 Asia-Pacific Animal Drug Compounding by Region
7.1 Asia-Pacific Animal Drug Compounding Historic Market Size by Region
7.1.1 Asia-Pacific Animal Drug Compounding Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Animal Drug Compounding Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Animal Drug Compounding Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Animal Drug Compounding Forecasted Market Size by Region
7.2.1 Asia-Pacific Animal Drug Compounding Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Animal Drug Compounding Sales in Value by Region (2024-2029)
8 Latin America Animal Drug Compounding by Country
8.1 Latin America Animal Drug Compounding Historic Market Size by Country
8.1.1 Latin America Animal Drug Compounding Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Animal Drug Compounding Sales in Volume by Country (2018-2023)
8.1.3 Latin America Animal Drug Compounding Sales in Value by Country (2018-2023)
8.2 Latin America Animal Drug Compounding Forecasted Market Size by Country
8.2.1 Latin America Animal Drug Compounding Sales in Volume by Country (2024-2029)
8.2.2 Latin America Animal Drug Compounding Sales in Value by Country (2024-2029)
9 Middle East and Africa Animal Drug Compounding by Country
9.1 Middle East and Africa Animal Drug Compounding Historic Market Size by Country
9.1.1 Middle East and Africa Animal Drug Compounding Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Animal Drug Compounding Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Animal Drug Compounding Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Animal Drug Compounding Forecasted Market Size by Country
9.2.1 Middle East and Africa Animal Drug Compounding Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Animal Drug Compounding Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Triangle Compounding Pharmacy
10.1.1 Triangle Compounding Pharmacy Company Information
10.1.2 Triangle Compounding Pharmacy Introduction and Business Overview
10.1.3 Triangle Compounding Pharmacy Animal Drug Compounding Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Triangle Compounding Pharmacy Animal Drug Compounding Products Offered
10.1.5 Triangle Compounding Pharmacy Recent Development
10.2 Lorraine's Pharmacy
10.2.1 Lorraine's Pharmacy Company Information
10.2.2 Lorraine's Pharmacy Introduction and Business Overview
10.2.3 Lorraine's Pharmacy Animal Drug Compounding Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lorraine's Pharmacy Animal Drug Compounding Products Offered
10.2.5 Lorraine's Pharmacy Recent Development
10.3 Medisca
10.3.1 Medisca Company Information
10.3.2 Medisca Introduction and Business Overview
10.3.3 Medisca Animal Drug Compounding Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medisca Animal Drug Compounding Products Offered
10.3.5 Medisca Recent Development
10.4 Diamondback Drugs
10.4.1 Diamondback Drugs Company Information
10.4.2 Diamondback Drugs Introduction and Business Overview
10.4.3 Diamondback Drugs Animal Drug Compounding Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Diamondback Drugs Animal Drug Compounding Products Offered
10.4.5 Diamondback Drugs Recent Development
10.5 ESSENTIAL PHARMACY COMPOUNDING VET
10.5.1 ESSENTIAL PHARMACY COMPOUNDING VET Company Information
10.5.2 ESSENTIAL PHARMACY COMPOUNDING VET Introduction and Business Overview
10.5.3 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ESSENTIAL PHARMACY COMPOUNDING VET Animal Drug Compounding Products Offered
10.5.5 ESSENTIAL PHARMACY COMPOUNDING VET Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Animal Drug Compounding Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Animal Drug Compounding Industrial Chain Analysis
11.4 Animal Drug Compounding Market Dynamics
11.4.1 Animal Drug Compounding Industry Trends
11.4.2 Animal Drug Compounding Market Drivers
11.4.3 Animal Drug Compounding Market Challenges
11.4.4 Animal Drug Compounding Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Animal Drug Compounding Distributors
12.3 Animal Drug Compounding Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
